Iradimed earnings were $23.1M for the trailing 12 months ending Jun 30, 2026, with 11.7% growth year over year. The latest IRMD earnings report on Jun 30, 2026 announced Q2 2026 earnings of $5.2M, down 10.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IRMD reported annual earnings of $22.5M, with 16.9% growth.
IRMD past earnings growth
How has IRMD's earnings growth performed historically?
On IRMD's earnings call on Jul 31, 2026, Iradimed (NASDAQ: IRMD) reported Q2 2026 earnings per share (EPS) of $0.41, up 8.89% year over year. Total IRMD earnings for the quarter were $5.22 million. In the same quarter last year, Iradimed's earnings per share (EPS) was $0.45.
As of the last Iradimed earnings report, Iradimed is currently profitable. Iradimed's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $23.05 million, a 11.61% increase year over year.
What was IRMD's earnings growth in the past year?
As of Iradimed's earnings date in Jul 31, 2026, Iradimed's earnings has grown 11.66% year over year. This is 15.6 percentage points higher than the US Medical Devices industry earnings growth rate of -3.94%. IRMD earnings in the past year totalled $23.05 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.